source
- Lycia Therapeutics raises $317.5 million in IPO as Merck halts sac-TMT trialLycia Therapeutics, founded by Nobel laureate Carolyn Bertozzi, priced its initial public offering at about $317.5 million, bringing total proceeds to roughly $318 million. The offering marks the…
- Pathos AI secures $237M Series E funding at $3B valuation, partners with Bristol Myers on neurosciencePathos AI, an AI-focused biotech based in New York, announced it has closed a Series E financing round raising $237 million. The round values the company at $3 billion, reflecting investor confide…